DKK1 and prostate carcinoma: In addition to PC3 prostate cancer cell, cancer cell lines related to breast cancer (SKBR3), gastric adenocarcinoma (NCI-N87) and colon cancer (Colo-205) were selected for evaluation of the DKK1 antibodies in the cytotoxicity assay to strengthen the clinical translational value.